CANF Can-Fite BioPharma Ltd. ADRs

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:CFBI.

$1.13  -0.04 (-3.42%)
As of 01/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  11/01/2012
Outstanding shares:  27,191,543
Average volume:  1,767,398
Market cap:   $30,998,359
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -2.79
PB ratio:   2.44
PS ratio:   38.80
Return on equity:   -129.96%
Net income %:   -1,518.15%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy